These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 30278461)
1. Mining Prognostic Significance of MEG3 in Human Breast Cancer Using Bioinformatics Analysis. Cui X; Yi Q; Jing X; Huang Y; Tian J; Long C; Xiang Z; Liu J; Zhang C; Tan B; Li Y; Zhu J Cell Physiol Biochem; 2018; 50(1):41-51. PubMed ID: 30278461 [TBL] [Abstract][Full Text] [Related]
2. Bioinformatics analysis of prognostic value of Chen WX; Cheng L; Xu LY; Qian Q; Zhu YL Biosci Rep; 2019 Mar; 39(3):. PubMed ID: 30837324 [No Abstract] [Full Text] [Related]
3. CD24 is a Potential Biomarker for Prognosis in Human Breast Carcinoma. Jing X; Cui X; Liang H; Hao C; Yang Z; Li X; Yang X; Han C Cell Physiol Biochem; 2018; 48(1):111-119. PubMed ID: 30001552 [TBL] [Abstract][Full Text] [Related]
4. Overexpression of MUC1 predicts poor prognosis in patients with breast cancer. Jing X; Liang H; Hao C; Yang X; Cui X Oncol Rep; 2019 Feb; 41(2):801-810. PubMed ID: 30483806 [TBL] [Abstract][Full Text] [Related]
5. Bioinformatics analysis of prognostic significance of COL10A1 in breast cancer. Zhang M; Chen H; Wang M; Bai F; Wu K Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32043519 [TBL] [Abstract][Full Text] [Related]
6. The expression and clinical significance of secretory leukocyte proteinase inhibitor (SLPI) in mammary carcinoma using bioinformatics analysis. Xie W; Zhang H; Qin S; Zhang J; Fan X; Yin Y; Liang R; Long H; Yi W; Fu D; Ma C; Lv M; Yu F Gene; 2019 Dec; 720():144088. PubMed ID: 31476404 [TBL] [Abstract][Full Text] [Related]
7. Cell division cycle proteinising prognostic biomarker of breast cancer. Cheng L; Huang YZ; Chen WX; Shi L; Li Z; Zhang X; Dai XY; Wei JF; Ding Q Biosci Rep; 2020 May; 40(5):. PubMed ID: 32285914 [TBL] [Abstract][Full Text] [Related]
8. Identification of prognostic significance of BIRC5 in breast cancer using integrative bioinformatics analysis. Dai JB; Zhu B; Lin WJ; Gao HY; Dai H; Zheng L; Shi WH; Chen WX Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32043523 [TBL] [Abstract][Full Text] [Related]
9. The prognostic value of long noncoding RNA MEG3 expression in the survival of patients with cancer: A meta-analysis. Binabaj MM; Bahrami A; Bahreyni A; Shafiee M; Rahmani F; Khazaei M; Soleimanpour S; Ghorbani E; Fiuji H; Ferns GA; Ryzhikov M; Avan A; Hassanian SM J Cell Biochem; 2018 Nov; 119(11):9583-9590. PubMed ID: 30129051 [TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA MEG3 regulates proliferation, apoptosis, and autophagy and is associated with prognosis in glioma. Zhao H; Wang X; Feng X; Li X; Pan L; Liu J; Wang F; Yuan Z; Yang L; Yu J; Su R; Zhang Y; Ma L J Neurooncol; 2018 Nov; 140(2):281-288. PubMed ID: 30284203 [TBL] [Abstract][Full Text] [Related]
11. Down-regulation of long non-coding RNA MEG3 indicates an unfavorable prognosis in non-small cell lung cancer: Evidence from the GEO database. Zhang Z; Liu T; Wang K; Qu X; Pang Z; Liu S; Liu Q; Du J Gene; 2017 Sep; 630():49-58. PubMed ID: 28782577 [TBL] [Abstract][Full Text] [Related]
12. Bioinformatics analysis of prognostic value of PITX1 gene in breast cancer. Wang Q; Zhao S; Gan L; Zhuang Z Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32830857 [TBL] [Abstract][Full Text] [Related]
13. Hypermethylation of lncRNA MEG3 impairs chemosensitivity of breast cancer cells. Li H; Wang P; Liu J; Liu W; Wu X; Ding J; Kang J; Li J; Lu J; Pan G J Clin Lab Anal; 2020 Sep; 34(9):e23369. PubMed ID: 32618397 [TBL] [Abstract][Full Text] [Related]
14. Down-regulation of long non-coding RNA MEG3 serves as an unfavorable risk factor for survival of patients with breast cancer. Zhang JJ; Guo SH; Jia BQ Eur Rev Med Pharmacol Sci; 2016 Dec; 20(24):5143-5147. PubMed ID: 28051255 [TBL] [Abstract][Full Text] [Related]
16. Decreased expression of long noncoding RNA MEG3 affects cell proliferation and predicts a poor prognosis in patients with colorectal cancer. Yin DD; Liu ZJ; Zhang E; Kong R; Zhang ZH; Guo RH Tumour Biol; 2015 Jun; 36(6):4851-9. PubMed ID: 25636452 [TBL] [Abstract][Full Text] [Related]
17. Promoter hypermethylation-mediated downregulation of miR-770 and its host gene MEG3, a long non-coding RNA, in the development of gastric cardia adenocarcinoma. Guo W; Dong Z; Liu S; Qiao Y; Kuang G; Guo Y; Shen S; Liang J Mol Carcinog; 2017 Aug; 56(8):1924-1934. PubMed ID: 28345805 [TBL] [Abstract][Full Text] [Related]
18. Downregulation of long noncoding RNA MEG3 is associated with poor prognosis and promoter hypermethylation in cervical cancer. Zhang J; Lin Z; Gao Y; Yao T J Exp Clin Cancer Res; 2017 Jan; 36(1):5. PubMed ID: 28057015 [TBL] [Abstract][Full Text] [Related]
19. Hypermethylation of BRCA1 gene: implication for prognostic biomarker and therapeutic target in sporadic primary triple-negative breast cancer. Zhu X; Shan L; Wang F; Wang J; Wang F; Shen G; Liu X; Wang B; Yuan Y; Ying J; Yang H Breast Cancer Res Treat; 2015 Apr; 150(3):479-86. PubMed ID: 25783183 [TBL] [Abstract][Full Text] [Related]
20. LncRNA MEG3 inhibits cell epithelial-mesenchymal transition by sponging miR-421 targeting E-cadherin in breast cancer. Zhang W; Shi S; Jiang J; Li X; Lu H; Ren F Biomed Pharmacother; 2017 Jul; 91():312-319. PubMed ID: 28463794 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]